ARS Pharmaceuticals Launches neffyinSchools Program Providing Free Life-Saving Needle-Free Epinephrine For Emergency Use to Eligible K-12 Schools
(NasdaqGM:SPRY), School administrators and nurses are encouraged to review applicable state laws and regulations to ensure neffy(R) (epinephrine nasal spray) 2 mg for undesignated use meets applicable state law requirements Interested schools can visit neffy.com/community-programs to apply SAN DIEGO, Jan. 21, 2025 (GLOBE NEWSWIRE) — ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to […]